导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -16.51% | 4490/4982 |
| 近一周 | -6.71% | 5389/5417 |
| 近一月 | -12.62% | 5384/5423 |
| 近一季 | -29.84% | 5326/5376 |
| 近半年 | -22.95% | 4925/5131 |
| 近一年 | 23.17% | 938/4741 |
| 近两年 | 89.23% | 1161/4208 |
| 近三年 | 18.71% | 2321/3661 |
| 成立以来 | 198.35% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
15.76% 70/5130 |
-6.22% 3992/5464 |
- - |
- - |
| 2025 | 80.74% 200/5130 |
-2.98% 4309/4624 |
1.86% 2416/4802 |
35.04% 1175/4970 |
35.43% 3/5130 |
| 2024 | -21.11% 4047/4618 |
-20.83% 4178/4340 |
-16.31% 4279/4442 |
24.00% 85/4550 |
-3.99% 2806/4618 |
| 2023 | -31.71% 3419/4216 |
-7.79% 3449/3759 |
-7.92% 2975/3909 |
-20.54% 3775/4055 |
1.23% 327/4209 |
| 2022 | -20.49% 1231/3578 |
-12.94% 577/2804 |
21.26% 50/3205 |
-16.62% 2666/3430 |
-9.68% 3215/3570 |
| 2021 | 17.47% 398/2717 |
-8.83% 1378/1745 |
31.14% 87/2232 |
3.58% 435/2560 |
-5.14% 2140/2708 |
| 2020 | 54.79% 535/1596 |
-0.77% 459/1036 |
18.03% 770/1256 |
10.10% 659/1472 |
20.04% 298/1690 |
| 2019 | 48.38% 265/926 |
30.51% 417/3054 |
-8.33% 2889/3201 |
8.38% 300/939 |
14.42% 111/1014 |
| 2018 | -20.45% 173/668 |
- - |
- - |
- - |
-7.71% 1567/2977 |
| 2017 | 7.31% 310/531 |
- - |
- - |
- - |
- - |
| 2016 | -18.41% 272/455 |
- - |
- - |
- - |
- - |
| 2015 | 25.25% 337/433 |
- - |
- - |
- - |
- - |
| 2014 | 52.25% 26/432 |
- - |
- - |
- - |
- - |
| 2013 | 15.60% 180/398 |
- - |
- - |
- - |
- - |
| 2012 | 9.16% 111/459 |
- - |
- - |
- - |
- - |
| 2011 | -21.48% 137/392 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 54.69% |
| 招商创新增长混合A | 1.0759 | 54.25% |
| 招商创新增长混合C | 1.0235 | 53.96% |
| 华泰柏瑞医疗健康A | 2.6422 | 49.29% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 招商品质成长混合A | 1.0435 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 47.23% |
| 大摩优悦安和混合C | 0.8828 | 47.08% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 大摩健康产业混合A | 1.9440 | 32.70% |
| 泰信发展主题混合 VS. 长安宏观策略混合A(740001) |